JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML

Riikka Karjalainen, Tea Pemovska, Mihaela Popa, Minxia Liu, Komal K. Javarappa, Muntasir M. Majumder, Bhagwan Yadav, David Tamborero, Jing Tang, Dmitrii Bychkov, Mika Kontro, Alun Parsons, Minna Suvela, Mireia Mayoral Safont, Kimmo Porkka, Tero Aittokallio, Olli Kallioniemi, Emmet McCormack, Bjorn T. Gjertsen, Krister WennerbergJonathan Knowles, Caroline A. Heckman

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalBlood
Volume130
Issue number6
Pages (from-to)789-802
Number of pages14
ISSN0006-4971
DOIs
Publication statusPublished - 10 Aug 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • ACUTE MYELOID-LEUKEMIA
  • TYROSINE KINASE INHIBITOR
  • MUTANT FLT3-POSITIVE AML
  • DRUG-RESISTANCE
  • UP-REGULATION
  • STEM-CELLS
  • FLT3
  • MICROENVIRONMENT
  • PATHWAY
  • PKC412
  • 3122 Cancers
  • 3111 Biomedicine

Cite this